Regis Healthcare reacts to government funding change

Regis Healthcare says government funding will rise just 2.55% as wage and cost inflation run much higher across the sector.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is in focus after the company noted only a 2.55% increase to the industry-wide government funding rate, with inflation and wage pressures running well ahead of this increase.

Couple looking ahead with laptop open at a table.

Image source: Getty Images

What did Regis Healthcare report?

  • The AN-ACC starting price will rise 2.55% from $295.64 to $303.19 per resident per day from 1 October 2026
  • The hotelling supplement will remain at $22.15 per resident per day
  • Government has kept the care minute requirements and funding categories unchanged
  • Recent cost drivers: 4.75% wage increase for award-based workers; up to 4.4% increase for nurses; 3.8% CPI growth

What else do investors need to know?

Regis Healthcare pointed out that the 2.55% funding uplift lags well behind sector cost growth, driven by higher wages and inflation. The annual wage review and recent Fair Work Commission decisions mean that wages for nurses and care staff are rising significantly faster than aged care government reimbursement.

The company reaffirmed its strategy to manage ongoing margin pressure, noting initiatives such as raising room prices, rolling out Higher Everyday Living Fee (HELF) services, and enhancing both revenue optimisation and operational efficiency.

What's next for Regis Healthcare?

Regis says it will continue advocating for adequate sector funding to support growing demand for residential aged care. Its ongoing strategy to mitigate rising costs includes service enhancements, pricing adjustments, and operational improvements.

The company remains focused on delivering high-quality care to its 10,000 residents and clients, supported by a 13,000-strong team, while navigating ongoing policy and inflationary challenges.

Regis Healthcare share price snapshot

Over the past 12 months, Regis Healthcare shares have declined 23%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Top 3 ASX healthcare shares to buy after a brutal year

Three very different ways to back healthcare.

Read more »

A kid stretches up to reach the top of the ruler drawn on the wall behind.
Healthcare Shares

Why brokers see 85% upside for this ASX biotech stock

This biotech combines growing revenue, pipeline catalysts, and significant upside.

Read more »

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Healthcare Shares

Is the ResMed share price too cheap to ignore?

I think this stock still has a huge global growth opportunity, and the current valuation doesn't capture this.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

Could this ASX healthcare stock really be set to rise 400%? Morgans thinks so 

This exciting stock could be set to explode.

Read more »

A woman is very excited about something she's just seen on her computer, clenching her fists and smiling broadly.
Healthcare Shares

Telix shares are up 98%: Is there more upside to come?

The bull case remains compelling: rapid growth, rising profits and broker optimism.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Healthcare Shares

How CSL shares skyrocketed 39% in August

Investors sent CSL shares rocketing 39% in August. But why?

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Healthcare Shares

Sonic Healthcare shares crash 21%: What on earth is going on?

Do you hold the ASX healthcare shares in your portfolio?

Read more »

A doctor looks unsure.
Healthcare Shares

CSL shares rebound 86%: Is the ASX biotech stock a buy, sell or hold for September?

Find out why investors are now rushing to buy CSL shares.

Read more »